# ML v2 Post-CP15 Completion Packet

This packet consolidates the CP-01 through CP-15 ML v2 roadmap and the
post-CP-15 blocker-resolution loops completed after the original final research
packet. It is paper-only and not live-ready.

## Final Recommendation

`paper_only_complete_blocked_not_live_ready`

The ML v2 research packet is complete for the current paper-only roadmap, but
training execution, experiment execution, production readiness, candidate
promotion, broker submission, and trading remain blocked.

## Checkpoint And Commit Summary

- CP-01 through CP-15: complete in `data/reports/ml_v2_final_research_packet.*`.
- Post-CP15 commits:
  - `f982b11` Add formulaic alpha feature materialization plan
  - `c179c9d` Materialize formulaic alpha feature sample
  - `2c9745d` Refresh ML v2 readiness after feature sample
  - `9df10f1` Add broader formulaic materialization coverage plan
  - `941141a` Materialize broader formulaic feature stage 1
  - `28b1a09` Refresh ML v2 readiness after stage 1 features
  - `e008a1a` Add ML v2 stage 1 experiment gate design
  - `c3046cf` Add ML v2 stage 1 experiment gate
  - `53009d3` Add ML v2 stage 1 tiny experiment protocol
  - `bb7e236` Add ML v2 stage 1 tiny experiment execution gate

## Blockers And Gate State

- Deflated Sharpe is a placeholder only; it has not been calculated.
- Effective trial count remains `not_available` where exact evidence is not
  computable from existing reports.
- Stage 1 feature coverage improved to a bounded sample, but it is not full
  universe/date merge readiness.
- Stage 1 ML v2 training readiness remains `BLOCK`.
- POST-04 blocks tiny experiment execution.
- OOS review and production readiness remain blocked.

## Feature Coverage

Stage 1 broader materialization created a bounded paper-only formulaic feature
sample with 7200 rows, 50 symbols, 24 feature dates, and six formula hashes.
This is useful research evidence, but it remains sample-level coverage and does
not authorize training or model selection.

## PIT, Leakage, And Validation

The Stage 1 feature audit records PIT and label-isolation checks, and the
purged/embargo validation schema exists. Validation execution was not run in
this packet, and no OOS rerun was performed.

## Trial Ledger And Data-Snooping Controls

The candidate trial ledger and Deflated Sharpe placeholder exist. The ledger is
not used to promote or demote any candidate, and the placeholder does not
support Sharpe, PnL ranking, model selection, or formula selection claims.
The effective trial count remains unavailable where exact evidence cannot be
computed from existing local reports.

## Cost, Concentration, And Failure Evidence

Cost, slippage, concentration, and failure-analysis reports exist as paper-only
risk evidence. They do not change strategy parameters, protected candidate
status, or production readiness.

## Overlay

Macro, disclosure, news, CEO/SNS, sentiment, and LLM/agentic references remain
disabled-by-default risk-overlay inputs only. No external data was fetched and
no API, SNS, or news scraping was performed.

## Safety State

- production: `BLOCK`
- protected_candidate: `PAPER_REVIEW`
- training_allowed_now: `False`
- candidate_promotion: `False`
- broker_submission: `False`
- order_execution: `False`
- trading_allowed: `False`
- production_effect: `none`
- push_performed: `False`

## Stop Condition

No remaining safe local report/design/audit/readiness loop is identified within
the current ML v2 / post-CP-15 blocker-resolution roadmap. Further progress
would require a new explicitly authorized research goal or a future approval to
address blocked training, validation, external data, or production-readiness
work.
